Streetbeat News

Stock Prices

PM

Philip Morris Intl (NYSE:PM) has seen unusual options activity with a bullish stance from large investors. 45% of trades were bullish, with a significant amount of calls compared to puts. Analysts have mixed ratings, with target prices ranging from $105 to $145.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 8:02 pm

SCHW

Recent unusual options activity for Charles Schwab (SCHW) shows a bearish sentiment among big-money investors, with 70% of trades being puts. This suggests potential negative expectations for the stock, which is currently trading at $64.08. An analyst from Wells Fargo downgraded the stock to Equal-Weight with a price target of $70.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 8:02 pm

MLM

Martin Marietta Materials (NYSE:MLM) has outperformed the market over the past decade with an average annual return of 15.33%, resulting in a $100 investment growing to $413.96. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 8:00 pm

FI

Fiserv (NYSE:FI) has significantly outperformed the market over the past decade, with an annualized return of 18.49%. A $100 investment in Fiserv 10 years ago would now be worth $546.73, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 8:00 pm

DE

Former President Donald Trump has threatened to impose a 200% tariff on John Deere products if the company shifts production from the U.S. to Mexico. This could negatively impact Deere & Co's stock price and investors, including some members of Congress. The threat has drawn criticism from figures like Mark Cuban, who argue it could harm the company. Deere shares are currently trading at $407.40.

Portfolio Pulse from Chris Katje

September 25, 2024 | 7:54 pm

LUV

Southwest Airlines shares are declining due to a report indicating potential reductions in service and staffing in Atlanta.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:51 pm

ASND

BMRN

BioMarin Pharmaceutical Inc. remains confident in its 2027 revenue target despite competition from Ascendis Pharma. Goldman Sachs maintains a Buy rating on BioMarin, highlighting potential growth from Voxzogo and external business development. BioMarin is implementing a cost transformation program to achieve its financial goals.

Portfolio Pulse from Vandana Singh

September 25, 2024 | 7:50 pm

SAP

SAP shares are declining due to reports of a DOJ investigation into alleged price fixing involving SAP and Carahsoft.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:50 pm

NOW

ServiceNow shares are experiencing a decline, potentially due to the Department of Justice's investigation into Carahsoft. This development may be causing investor concern and impacting the stock's performance.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 7:49 pm

META

Meta Platforms Inc. shares rose following announcements at the 'Meta Connect 2024' event, including new AI, VR, and AR products. Highlights include the Quest 3S headset, updates to Ray-Ban Meta smart glasses, and the introduction of 'Orion' AR glasses. Meta's AI chatbot usage and AI tools for businesses are also expanding.

Portfolio Pulse from Vaishali Prayag

September 25, 2024 | 7:44 pm